Hoerter Steven L. insider trades
Hoerter Steven L. has filed 30 Form 4s with the SEC that we hold, for MBX Biosciences, Inc. (MBX) (President and CEO, Director), CIK 1654151 (President and CEO, Director), Oric Pharmaceuticals, Inc. (ORIC) (Director) and C4 Therapeutics, Inc. (CCCC) (Director), among 5 companies in all. Across all of them we count 1 purchase worth $265.0K and 4 sales worth $1.3M reported on Form 4. In the last 12 months: 1 purchase ($265.0K) and 0 sales ($0). The largest single trade was a sale of 30,045 shares of DCPH worth $480.7K, dated 2023-02-14. The first filing on our record is dated 2021-07-19 and the latest 2026-08-04.
MBX Biosciences, Inc. (MBX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-10-17 | P, purchase reported on Form 4 | 20,000 | $265.0K | 2025-10-20 |
CIK 1654151
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-02-14 | S, sale reported on Form 4 | 30,045 | $480.7K | 2023-02-16 |
| 2023-03-21 | S, sale reported on Form 4 | 7,500 | $116.8K | 2023-03-23 |
| 2023-10-30 | S, sale reported on Form 4 | 21,573 | $259.3K | 2023-10-31 |
| 2023-12-13 | S, sale reported on Form 4 | 30,664 | $471.3K | 2023-12-14 |
Oric Pharmaceuticals, Inc. (ORIC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
C4 Therapeutics, Inc. (CCCC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
CNST
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1533451) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms